Manufacturing and Analytical Services
Looking to Outsource Your Drug Development and Manufacturing?
Your Drug Development and Manufacturing Partner ― Altasciences at a Glance
Altasciences can support your drug formulation, development, and manufacturing needs, from formulation through to commercialization.
We excel in the full range of drug development and manufacturing solutions, including:
- Handling complex formulations and highly potent compounds (HPAPIs)
- Custom formulation development
- Manufacturing of liquid-filled, hard-shell capsules
- Nanomilling – to resolve solubility and bioavailability challenges
- Terminal sterilization
In addition, our integrated CRO/CDMO end-to-end solutions can reduce your drug development program timeline by up to 40% ― from discovery to preclinical to clinical proof of concept, and beyond.
Partner with us today.
Got a few more minutes?
| See our full range of drug development and manufacturing solutions. | Take a tour of our manufacturing facility and analytical laboratories. |
 |
 |
Did you miss our webinar titled “The Development of Nanosuspension Formulations for Poorly Soluble Drugs”? View it ON-DEMAND!
Liquid-Filled Capsules – The Key to Accelerating Drug Development
Benefits of Liquid-Filled Capsules for Pharmaceutical Development
Liquid-filled, hard-shell capsules (LFCs) offer many advantages over tablet and other solid oral dosage formulations, including quicker drug development.
In this e-book, learn about:
- The top five benefits of LFCs over other solid oral dosage forms
- Applications for challenging APIs
- Logistical advantages
- How liquid filling works
- Advances in capsule binding technology
- Customization options
Questions? Speak with one of our experts.
Did you miss our webinar titled “The Development of Nanosuspension Formulations for Poorly Soluble Drugs”? View it ON-DEMAND!
Benefits of Liquid-Filled Capsules in Pharmaceutical Development
Five Things You Need to Know About Partnering with an Integrated CRO/CDMO
We are often asked about the advantages of working with an integrated CRO/CDMO.
Top Scientific Resources of 2021
|
||||||
|
With the year coming to an end, we rounded-up some of our most insightful scientific resources from 2021. Check out what you may have missed, discover more about our areas of expertise, and learn how we can help you accelerate your drug development program. |
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
Have five more minutes? You may be interested in:
|
FDA and EMA Prefer Terminal Sterilization Over Aseptic Manufacturing ― Find Out Why
Advantages of Terminal Sterilization Over Aseptic Manufacturing
Regulatory agencies such as the FDA and EMA generally prefer terminal sterilization over aseptic manufacturing, as it provides a high level of sterility assurance. It is also less complex, less costly, more easily reproducible than aseptic manufacturing, and offers time savings to pharmaceutical companies.
In this issue of The Altascientist, we discuss:
- Differences between terminal sterilization and aseptic manufacturing
- Sterilization methods for pharmaceutical products
- Validation steps during sterilization
- Method selection
Read to learn how terminal sterilization can benefit your drug product.
Questions? Speak with one of our experts? Contact Us.
Start Your Clinical Trials Sooner
Our clinical trial experts set your drug development program up for success by proactively preparing and performing each critical moving part while others are underway. As a single source for early phase drug development solutions, we integrate and synchronize key CRO/CDMO activities, such as clinic-ready manufacturing, bioanalysis, clinical study conduct, and regulatory review, so that you’re always ready for the next step.
Check out how we do this and experience the difference.
You may also be interested in the following:
Webpages:
Fact Sheet:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Psychedelics — Regulatory Environment Challenges
A History of Public Attitude Towards Psychedelic Drugs
Psychedelic drugs exist within a unique social, legal, and historical environment, with roots in the public imag
How to Overcome Formulation Challenges in Drug Development
Over 80% of drugs will fail during clinical development ― formulation challenges and lack of efficacy being the major causes.
How do we overcome these challenges?
Altasciences’ integrated approach combines formulation development for preclinical and clinical studies, analytical assay development and validation, excipient screening, GMP manufacturing, as well as finished product and release testing ― seamlessly transitioning your project from R&D to clinical supply.
Our expertise includes:
- Scale-up and clinical/commercial manufacturing of drug products with complex formulations
- Developing and manufacturing of liquid-filled, hard-shell capsules required for poorly soluble molecules and difficult formulations
- Handling of potent compounds and controlled substances (Schedules I-V), with expertise in cannabinoids and psychedelic/hallucinogenic drugs
- Manufacturing of wet nanomilled suspensions with scales up to 2,000 L
By partnering with Altasciences, you will:
- Reduce your timelines
- Improve and accelerate critical decision making
- Minimize risk of product failure
Trust your drug product development to a reliable, experienced CDMO.
Contact us.
You may also be interested in the following: